Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:2248-2254

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Subbanagounder, G.
Right arrow Articles by Berliner, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Subbanagounder, G.
Right arrow Articles by Berliner, J. A.
Related Collections
Right arrow Lipids
Right arrow Lipid and lipoprotein metabolism
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Mechanism of atherosclerosis/growth factors
Right arrow Risk Factors
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:2248.)
© 2000 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Determinants of Bioactivity of Oxidized Phospholipids

Specific Oxidized Fatty Acyl Groups at the sn-2 Position

Ganesamoorthy Subbanagounder; Norbert Leitinger; Dawn C. Schwenke; Jason W. Wong; Hans Lee; Christina Rizza; Andrew D. Watson; Kym F. Faull; Alan M. Fogelman; Judith A. Berliner

From the Departments of Medicine (G.S., N.L., J.W.W., H.L., C.R., A.D.W., A.M.F., J.A.B.) and Pathology (J.A.B.) and the Pasarow Mass Spectrometry Laboratory (K.F.F.) and Department of Psychiatry and Biobehavioral Sciences and Neuropsychiatric Institute, University of California, Los Angeles, and the Department of Pathology (D.C.S.), Wake Forest University School of Medicine, Winston-Salem, NC. Norbert Leitinger is currently at the Department of Vascular Biology and Thrombosis Research, University of Vienna, Vienna, Austria.

Correspondence to Ganesamoorthy Subbanagounder, PhD, Department of Medicine/Cardiology, 47-123, Center for the Health Sciences, UCLA Medical Center, Los Angeles, CA 90095-1679. E-mail gsubbanagounder{at}mednet.ucla.edu

Abstract—We previously described 3 bioactive oxidation products of 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (PAPC) containing oxovaleroyl (POVPC), glutaroyl (PGPC), and epoxyisoprostane (PEIPC) groups at the sn-2 position that were increased in minimally modified/oxidized low density lipoprotein (MM-LDL) and rabbit atherosclerotic lesions. We demonstrated specific and contrasting effects of POVPC and PGPC on leukocyte-endothelial interactions and described an effect of PEIPC on monocyte binding. The major purpose of the present study was to determine the effects of structural changes on the bioactivities of these 3 lipids. We demonstrate herein that the group at the sn-2 position determines the specific bioactivity and that the substitution of stearoyl for palmitoyl at the sn-1 position or ethanolamine for choline at the sn-3 position of the phospholipid did not alter bioactivity. Oxidized PAPC, oxidized 1-stearoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine, and oxidized 1-stearoyl-2-arachidonoyl-sn-glycero-3-phosphorylethanolamine stimulated monocyte binding and inhibited lipopolysaccharide-induced expression of the neutrophil-binding molecule E-selectin. Furthermore, all oxovaleroyl phospholipids but not the glutaroyl phospholipids induced monocyte binding without an increase in vascular cell adhesion molecule-1 (VCAM-1) expression and inhibited lipopolysaccharide-induced E-selectin expression. In contrast, glutaroyl phospholipids but not oxovaleroyl phospholipids stimulated E-selectin and VCAM-1 expression. We further demonstrate that all parts of the phospholipid molecules are required for these bioactivities. Hydrolysis with phospholipase (PL) A1, PLA2, and PLC strongly reduced the bioactivities of POVPC, PGPC, and mixed isomers of PEIPC. PLD had a smaller but still significant effect. The effects of POVPC and PEIPC could be abolished by sodium borohydride treatment, indicating the importance of the reducible groups (carbonyl and epoxide) in these molecules. In summary, these studies identify 6 new bioactive, oxidized phospholipids that are increased in MM-LDL and, where measured, in atherosclerotic lesions. They thus suggest that a family of phospholipid oxidation products containing oxovaleroyl, glutaroyl, and epoxyisoprostane at the sn-2 position play an important role in the regulation of leukocyte-endothelial interactions, bioactivity being in part controlled by several types of phospholipid hydrolases.


Key Words: atherosclerosis • oxidized phospholipids • monocyte-endothelial interactions • E-selectin • phospholipases




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. Erridge, S. Kennedy, C. M. Spickett, and D. J. Webb
Oxidized Phospholipid Inhibition of Toll-like Receptor (TLR) Signaling Is Restricted to TLR2 and TLR4: ROLES FOR CD14, LPS-BINDING PROTEIN, AND MD2 AS TARGETS FOR SPECIFICITY OF INHIBITION
J. Biol. Chem., September 5, 2008; 283(36): 24748 - 24759.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
O. V. Oskolkova, T. Afonyushkin, A. Leitner, E. von Schlieffen, P. S. Gargalovic, A. J. Lusis, B. R. Binder, and V. N. Bochkov
ATF4-dependent transcription is a key mechanism in VEGF up-regulation by oxidized phospholipids: critical role of oxidized sn-2 residues in activation of unfolded protein response
Blood, July 15, 2008; 112(2): 330 - 339.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H.-K. Jyrkkanen, E. Kansanen, M. Inkala, A. M. Kivela, H. Hurttila, S. E. Heinonen, G. Goldsteins, S. Jauhiainen, S. Tiainen, H. Makkonen, et al.
Nrf2 Regulates Antioxidant Gene Expression Evoked by Oxidized Phospholipids in Endothelial Cells and Murine Arteries In Vivo
Circ. Res., July 3, 2008; 103(1): e1 - e9.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Davis, G. Koster, L. J. Douet, M. Scigelova, G. Woffendin, J. M. Ward, A. Smith, J. Humphries, K. G. Burnand, C. H. Macphee, et al.
Electrospray Ionization Mass Spectrometry Identifies Substrates and Products of Lipoprotein-associated Phospholipase A2 in Oxidized Human Low Density Lipoprotein
J. Biol. Chem., March 7, 2008; 283(10): 6428 - 6437.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
B. G. Gugiu, K. Mouillesseaux, V. Duong, T. Herzog, A. Hekimian, L. Koroniak, T. M. Vondriska, and A. D. Watson
Protein targets of oxidized phospholipids in endothelial cells
J. Lipid Res., March 1, 2008; 49(3): 510 - 520.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. Lu, W. Jiang, J.-H. Yang, P.-Y. Chang, J. P. Walterscheid, H.-H. Chen, M. Marcelli, D. Tang, Y.-T. Lee, W. S.L. Liao, et al.
Electronegative LDL Impairs Vascular Endothelial Cell Integrity in Diabetes by Disrupting Fibroblast Growth Factor 2 (FGF2) Autoregulation
Diabetes, January 1, 2008; 57(1): 158 - 166.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
B. J. Van Lenten, A. C. Wagner, M. Navab, G. M. Anantharamaiah, S. Hama, S. T. Reddy, and A. M. Fogelman
Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits
J. Lipid Res., November 1, 2007; 48(11): 2344 - 2353.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Gruber, O. Oskolkova, A. Leitner, M. Mildner, V. Mlitz, B. Lengauer, A. Kadl, P. Mrass, G. Kronke, B. R. Binder, et al.
Photooxidation Generates Biologically Active Phospholipids That Induce Heme Oxygenase-1 in Skin Cells
J. Biol. Chem., June 8, 2007; 282(23): 16934 - 16941.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. Moumtzi, M. Trenker, K. Flicker, E. Zenzmaier, R. Saf, and A. Hermetter
Import and fate of fluorescent analogs of oxidized phospholipids in vascular smooth muscle cells
J. Lipid Res., March 1, 2007; 48(3): 565 - 582.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Zimman, K. P. Mouillesseaux, T. Le, N. M. Gharavi, A. Ryvkin, T. G. Graeber, T. T. Chen, A. D. Watson, and J. A. Berliner
Vascular Endothelial Growth Factor Receptor 2 Plays a Role in the Activation of Aortic Endothelial Cells by Oxidized Phospholipids
Arterioscler. Thromb. Vasc. Biol., February 1, 2007; 27(2): 332 - 338.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. A. Walton, B. G. Gugiu, M. Thomas, R. J. Basseri, D. R. Eliav, R. G. Salomon, and J. A. Berliner
A role for neutral sphingomyelinase activation in the inhibition of LPS action by phospholipid oxidation products
J. Lipid Res., September 1, 2006; 47(9): 1967 - 1974.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. Huber, A. Furnkranz, V. N. Bochkov, M. K. Patricia, H. Lee, C. C. Hedrick, J. A. Berliner, B. R. Binder, and N. Leitinger
Specific monocyte adhesion to endothelial cells induced by oxidized phospholipids involves activation of cPLA2 and lipoxygenase
J. Lipid Res., May 1, 2006; 47(5): 1054 - 1062.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. Leitinger
A Rancid Culprit in Vascular Inflammation Acts on the Prostaglandin Receptor EP2
Circ. Res., March 17, 2006; 98(5): 587 - 589.
[Full Text] [PDF]


Home page
Circ. Res.Home page
R. Li, K. P. Mouillesseaux, D. Montoya, D. Cruz, N. Gharavi, M. Dun, L. Koroniak, and J. A. Berliner
Identification of Prostaglandin E2 Receptor Subtype 2 As a Receptor Activated by OxPAPC
Circ. Res., March 17, 2006; 98(5): 642 - 650.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Ninio, K. Winkler, M. M. Hoffmann, A. B. Grawitz, M. Nauck, B. R. Winkelmann, H. Scharnagl, W. Marz, and B. O. Bohm
Letter Regarding Article by Winkler et al, "Platelet-Activating Factor Acetylhydrolase Activity Indicates Angiographic Coronary Artery Disease Independently of Systemic Inflammation and Other Risk Factors: The Ludwigshafen Risk and Cardiovascular Health Study" * Response
Circulation, August 23, 2005; 112(8): e108 - e109.
[Full Text] [PDF]


Home page
J. Lipid Res.Home page
O. Quehenberger
Thematic Review Series: The Immune System and Atherogenesis. Molecular mechanisms regulating monocyte recruitment in atherosclerosis
J. Lipid Res., August 1, 2005; 46(8): 1582 - 1590.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. Boullier, P. Friedman, R. Harkewicz, K. Hartvigsen, S. R. Green, F. Almazan, E. A. Dennis, D. Steinberg, J. L. Witztum, and O. Quehenberger
Phosphocholine as a pattern recognition ligand for CD36,
J. Lipid Res., May 1, 2005; 46(5): 969 - 976.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. A. Z. Berry and R. C. Murphy
Analysis of cell membrane aminophospholipids as isotope-tagged derivatives
J. Lipid Res., May 1, 2005; 46(5): 1038 - 1046.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Zalewski and C. Macphee
Role of Lipoprotein-Associated Phospholipase A2 in Atherosclerosis: Biology, Epidemiology, and Possible Therapeutic Target
Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): 923 - 931.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Furnkranz, A. Schober, V. N. Bochkov, P. Bashtrykov, G. Kronke, A. Kadl, B. R. Binder, C. Weber, and N. Leitinger
Oxidized Phospholipids Trigger Atherogenic Inflammation in Murine Arteries
Arterioscler. Thromb. Vasc. Biol., March 1, 2005; 25(3): 633 - 638.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Srivastava, M. Spite, J. O. Trent, M. B. West, Y. Ahmed, and A. Bhatnagar
Aldose Reductase-catalyzed Reduction of Aldehyde Phospholipids
J. Biol. Chem., December 17, 2004; 279(51): 53395 - 53406.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. G. Birukov, V. N. Bochkov, A. A. Birukova, K. Kawkitinarong, A. Rios, A. Leitner, A. D. Verin, G. M. Bokoch, N. Leitinger, and Joe. G.N. Garcia
Epoxycyclopentenone-Containing Oxidized Phospholipids Restore Endothelial Barrier Function via Cdc42 and Rac
Circ. Res., October 29, 2004; 95(9): 892 - 901.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Yeh, A. L. Cole, J. Choi, Y. Liu, D. Tulchinsky, J.-H. Qiao, M. C. Fishbein, A. N. Dooley, T. Hovnanian, K. Mouilleseaux, et al.
Role for Sterol Regulatory Element-Binding Protein in Activation of Endothelial Cells by Phospholipid Oxidation Products
Circ. Res., October 15, 2004; 95(8): 780 - 788.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. H. Han, K. H. Hong, J. Ko, K. S. Rhee, M. K. Hong, J. J. Kim, Y. H. Kim, and S. J. Park
Lysophosphatidylcholine up-regulates CXCR4 chemokine receptor expression in human CD4 T cells
J. Leukoc. Biol., July 1, 2004; 76(1): 195 - 202.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. Navab, G. M. Ananthramaiah, S. T. Reddy, B. J. Van Lenten, B. J. Ansell, G. C. Fonarow, K. Vahabzadeh, S. Hama, G. Hough, N. Kamranpour, et al.
Thematic review series: The Pathogenesis of Atherosclerosis The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL
J. Lipid Res., June 1, 2004; 45(6): 993 - 1007.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
C. Zhang, D. L. Baker, S. Yasuda, N. Makarova, L. Balazs, L. R. Johnson, G. K. Marathe, T. M. McIntyre, Y. Xu, G. D. Prestwich, et al.
Lysophosphatidic Acid Induces Neointima Formation Through PPAR{gamma} Activation
J. Exp. Med., March 15, 2004; 199(6): 763 - 774.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Loidl, E. Sevcsik, G. Riesenhuber, H.-P. Deigner, and A. Hermetter
Oxidized Phospholipids in Minimally Modified Low Density Lipoprotein Induce Apoptotic Signaling via Activation of Acid Sphingomyelinase in Arterial Smooth Muscle Cells
J. Biol. Chem., August 29, 2003; 278(35): 32921 - 32928.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. A. Spector
Plaque Rupture, Lysophosphatidic Acid, and Thrombosis
Circulation, August 12, 2003; 108(6): 641 - 643.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. L. Cole, G. Subbanagounder, S. Mukhopadhyay, J. A. Berliner, and D. K. Vora
Oxidized Phospholipid-Induced Endothelial Cell/Monocyte Interaction Is Mediated by a cAMP-Dependent R-Ras/PI3-Kinase Pathway
Arterioscler. Thromb. Vasc. Biol., August 1, 2003; 23(8): 1384 - 1390.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. A. Walton, A. L. Cole, M. Yeh, G. Subbanagounder, S. R. Krutzik, R. L. Modlin, R. M. Lucas, J. Nakai, E. J. Smart, D. K. Vora, et al.
Specific Phospholipid Oxidation Products Inhibit Ligand Activation of Toll-Like Receptors 4 and 2
Arterioscler. Thromb. Vasc. Biol., July 1, 2003; 23(7): 1197 - 1203.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. R. Capote, F. X. McCormack, and F. Possmayer
Pulmonary Surfactant Protein-A (SP-A) Restores the Surface Properties of Surfactant after Oxidation by a Mechanism That Requires the Cys6 Interchain Disulfide Bond and the Phospholipid Binding Domain
J. Biol. Chem., May 30, 2003; 278(23): 20461 - 20474.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. Kobayashi, M. Kishi, T. Atsumi, M. L. Bertolaccini, H. Makino, N. Sakairi, I. Yamamoto, T. Yasuda, M. A. Khamashta, G. R. V. Hughes, et al.
Circulating oxidized LDL forms complexes with {beta}2-glycoprotein I: implication as an atherogenic autoantigen
J. Lipid Res., April 1, 2003; 44(4): 716 - 726.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Z. Ahmed, S. Babaei, G. F. Maguire, D. Draganov, A. Kuksis, B. N. La Du, and P. W. Connelly
Paraoxonase-1 reduces monocyte chemotaxis and adhesion to endothelial cells due to oxidation of palmitoyl, linoleoyl glycerophosphorylcholine
Cardiovasc Res, January 1, 2003; 57(1): 225 - 231.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
T. M. Forte, G. Subbanagounder, J. A. Berliner, P. J. Blanche, A. O. Clermont, Z. Jia, M. N. Oda, R. M. Krauss, and J. K. Bielicki
Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice
J. Lipid Res., March 1, 2002; 43(3): 477 - 485.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Friedman, S. Horkko, D. Steinberg, J. L. Witztum, and E. A. Dennis
Correlation of Antiphospholipid Antibody Recognition with the Structure of Synthetic Oxidized Phospholipids. IMPORTANCE OF SCHIFF BASE FORMATION AND ALDOL CONDENSATION
J. Biol. Chem., February 22, 2002; 277(9): 7010 - 7020.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Subbanagounder, J. W. Wong, H. Lee, K. F. Faull, E. Miller, J. L. Witztum, and J. A. Berliner
Epoxyisoprostane and Epoxycyclopentenone Phospholipids Regulate Monocyte Chemotactic Protein-1 and Interleukin-8 Synthesis. FORMATION OF THESE OXIDIZED PHOSPHOLIPIDS IN RESPONSE TO INTERLEUKIN-1beta
J. Biol. Chem., February 22, 2002; 277(9): 7271 - 7281.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
H. Kamido, H. Eguchi, H. Ikeda, T. Imaizumi, K. Yamana, K. Hartvigsen, A. Ravandi, and A. Kuksis
Core aldehydes of alkyl glycerophosphocholines in atheroma induce platelet aggregation and inhibit endothelium-dependent arterial relaxation
J. Lipid Res., January 1, 2002; 43(1): 158 - 166.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
V. N. Bochkov, D. Mechtcheriakova, M. Lucerna, J. Huber, R. Malli, W. F. Graier, E. Hofer, B. R. Binder, and N. Leitinger
Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca++/NFAT
Blood, January 1, 2002; 99(1): 199 - 206.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Navab, J. A. Berliner, G. Subbanagounder, S. Hama, A. J. Lusis, L. W. Castellani, S. Reddy, D. Shih, W. Shi, A. D. Watson, et al.
HDL and the Inflammatory Response Induced by LDL-Derived Oxidized Phospholipids
Arterioscler. Thromb. Vasc. Biol., April 1, 2001; 21(4): 481 - 488.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Ahmed, A. Ravandi, G. F. Maguire, A. Emili, D. Draganov, B. N. L. Du, A. Kuksis, and P. W. Connelly
Apolipoprotein A-I Promotes the Formation of Phosphatidylcholine Core Aldehydes That Are Hydrolyzed by Paraoxonase (PON-1) during High Density Lipoprotein Oxidation with a Peroxynitrite Donor
J. Biol. Chem., June 29, 2001; 276(27): 24473 - 24481.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Reddy, S. Hama, V. Grijalva, K. Hassan, R. Mottahedeh, G. Hough, D. J. Wadleigh, M. Navab, and A. M. Fogelman
Mitogen-activated Protein Kinase Phosphatase 1 Activity Is Necessary for Oxidized Phospholipids to Induce Monocyte Chemotactic Activity in Human Aortic Endothelial Cells
J. Biol. Chem., May 11, 2001; 276(20): 17030 - 17035.
[Abstract] [Full Text] [PDF]